June 15, 2020 / 6:08 PM / a month ago

BRIEF-Aim Immunotech Provides Update On Commercial Launch Of Ampligen In Argentina For Treatment Of Chronic Fatigue Syndrome

June 15 (Reuters) - AIM ImmunoTech Inc:

* AIM IMMUNOTECH - PROVIDES UPDATE ON COMMERCIAL LAUNCH OF AMPLIGEN IN ARGENTINA FOR TREATMENT OF CHRONIC FATIGUE SYNDROME

* AIM IMMUNOTECH - RECEIVES CLEARANCE FROM ARGENTINA’S FDA TO IMPORT FIRST SHIPMENT OF AMPLIGEN FOR COMMERCIAL SALE IN ARGENTINA

* AIM IMMUNOTECH - AIM SETS SIGHTS ON TREATING COVID-19 INDUCED CHRONIC FATIGUE IN ARGENTINA Source text - bit.ly/3fsf58J Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below